India's Pharmaceutical Firms Still Face Chinese Trade Barriers To Selling Drugs
This article was originally published in PharmAsia News
Indian drug makers say that they are finding it difficult to crack the China market for drugs and that even after entering the market, it is difficult to expand to take advantage of growing sales potential
You may also be interested in...
The team behind Russia’s first COVID-19 vaccine has asked for scientific advice from EU drug regulators in view of a possible submission for marketing authorization.
Great progress has been made in the treatment of RA with biologics and JAK inhibitors but there is a space for effective small-molecule therapies and Aclaris hopes to fill it with ATI-450.
With around half the French population vitamin D deficient, a group of medical experts say mass supplementation is a low cost and low risk intervention which could save lives and curb the spread of COVID-19.